Study of the immune state in different variants of anesthetic support for total laryngectomy

Peculiarities of operative interventions for malignant neoplasms of the larynx, their traumatic nature, and side effects of opioid use require the search for optimization of anesthesia and perioperative analgesia aimed at reducing surgically and anesthetically induced immunosuppression and related n...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu.Yu. Kobelyatskyi, I.O. Shkitak
Format: Article
Language:English
Published: Dnipro State Medical University 2023-06-01
Series:Medičnì Perspektivi
Subjects:
Online Access:https://journals.uran.ua/index.php/2307-0404/article/view/283264
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841564712640184320
author Yu.Yu. Kobelyatskyi
I.O. Shkitak
author_facet Yu.Yu. Kobelyatskyi
I.O. Shkitak
author_sort Yu.Yu. Kobelyatskyi
collection DOAJ
description Peculiarities of operative interventions for malignant neoplasms of the larynx, their traumatic nature, and side effects of opioid use require the search for optimization of anesthesia and perioperative analgesia aimed at reducing surgically and anesthetically induced immunosuppression and related negative consequences.Aim: to investigate the immune status of laryngeal cancer patients with different options of anesthetic support for total laryngectomy and to evaluate the relationship between perioperative im­munosuppression and the use of various adjuvant components of analgesia (dexmedetomidine and lidocaine).100 patients with T3-4N0-3M0 laryngeal cancer who underwent total laryngectomy were included in the study. Patients were evenly and comparably divided into 4 research groups (n=25) based on the main clinical and age-sex characteristics (p>0.05) depending on the use of adjuvant components of multimodal anesthesia: in the group 1 they were not used, only opioid analgesics, in group II – lidocaine was used, in group III – dexmedetomidine, and in group IV – both lidocaine and dexmedetomidine. Studies of markers of the immune state (leucoformula, IL-2 and TNF-α) were carried out on the 1st, 2nd, 5th and 7th days after surgery. Statistical analysis was carried out using STATISTICA v.6.1 (Statsoft Inc., USA, license number AGAR909E415822FA), it included parametric and non-parametric, and analytical statistics, parametric and non-parametric variance analysis descriptive of ANOVA, repeated measurements with an assessment of the degree of influence of an independent factor on the studied characteristic. A relatively stable state of cellular immunity and a certain suppression of humoral immunity after total laryngectomy was determined. Immunosuppression was most evident on the 2nd day after surgery in the  group 1 with standard opioid anesthesia. The best indicators of the immune state were determined in group IV of the study. The method of anesthesia had the greatest influence on the state of immunosuppression (according to TNF-ɑ) on the 2nd day after surgery – K=30.9% (p<0.001) and was observed within a week after surgery. Lidocaine and dexmedetomidine, as adjuvant components of multimodal anesthesia for total laryngectomy, when used together led to less immunosuppression, contributed to better rates of recovery of the immune status of laryngeal cancer patients compared  to the standard approach with the use of opioids.
format Article
id doaj-art-95de6a53780641819503c6f75bb74841
institution Kabale University
issn 2307-0404
language English
publishDate 2023-06-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-95de6a53780641819503c6f75bb748412025-01-02T22:35:30ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042023-06-01282859210.26641/2307-0404.2023.2.283264321485Study of the immune state in different variants of anesthetic support for total laryngectomyYu.Yu. Kobelyatskyi0https://orcid.org/0000-0002-8504-6125I.O. Shkitak1https://orcid.org/0000-0002-2019-6173Dnipro State Medical University, Volodymyra Vernadskoho str., 9, Dnipro, 49044Dnipro State Medical University, Volodymyra Vernadskoho str., 9, Dnipro, 49044Peculiarities of operative interventions for malignant neoplasms of the larynx, their traumatic nature, and side effects of opioid use require the search for optimization of anesthesia and perioperative analgesia aimed at reducing surgically and anesthetically induced immunosuppression and related negative consequences.Aim: to investigate the immune status of laryngeal cancer patients with different options of anesthetic support for total laryngectomy and to evaluate the relationship between perioperative im­munosuppression and the use of various adjuvant components of analgesia (dexmedetomidine and lidocaine).100 patients with T3-4N0-3M0 laryngeal cancer who underwent total laryngectomy were included in the study. Patients were evenly and comparably divided into 4 research groups (n=25) based on the main clinical and age-sex characteristics (p>0.05) depending on the use of adjuvant components of multimodal anesthesia: in the group 1 they were not used, only opioid analgesics, in group II – lidocaine was used, in group III – dexmedetomidine, and in group IV – both lidocaine and dexmedetomidine. Studies of markers of the immune state (leucoformula, IL-2 and TNF-α) were carried out on the 1st, 2nd, 5th and 7th days after surgery. Statistical analysis was carried out using STATISTICA v.6.1 (Statsoft Inc., USA, license number AGAR909E415822FA), it included parametric and non-parametric, and analytical statistics, parametric and non-parametric variance analysis descriptive of ANOVA, repeated measurements with an assessment of the degree of influence of an independent factor on the studied characteristic. A relatively stable state of cellular immunity and a certain suppression of humoral immunity after total laryngectomy was determined. Immunosuppression was most evident on the 2nd day after surgery in the  group 1 with standard opioid anesthesia. The best indicators of the immune state were determined in group IV of the study. The method of anesthesia had the greatest influence on the state of immunosuppression (according to TNF-ɑ) on the 2nd day after surgery – K=30.9% (p<0.001) and was observed within a week after surgery. Lidocaine and dexmedetomidine, as adjuvant components of multimodal anesthesia for total laryngectomy, when used together led to less immunosuppression, contributed to better rates of recovery of the immune status of laryngeal cancer patients compared  to the standard approach with the use of opioids.https://journals.uran.ua/index.php/2307-0404/article/view/283264anesthetic techniqueanesthetic agentimmunosuppressiontotal laryngectomy
spellingShingle Yu.Yu. Kobelyatskyi
I.O. Shkitak
Study of the immune state in different variants of anesthetic support for total laryngectomy
Medičnì Perspektivi
anesthetic technique
anesthetic agent
immunosuppression
total laryngectomy
title Study of the immune state in different variants of anesthetic support for total laryngectomy
title_full Study of the immune state in different variants of anesthetic support for total laryngectomy
title_fullStr Study of the immune state in different variants of anesthetic support for total laryngectomy
title_full_unstemmed Study of the immune state in different variants of anesthetic support for total laryngectomy
title_short Study of the immune state in different variants of anesthetic support for total laryngectomy
title_sort study of the immune state in different variants of anesthetic support for total laryngectomy
topic anesthetic technique
anesthetic agent
immunosuppression
total laryngectomy
url https://journals.uran.ua/index.php/2307-0404/article/view/283264
work_keys_str_mv AT yuyukobelyatskyi studyoftheimmunestateindifferentvariantsofanestheticsupportfortotallaryngectomy
AT ioshkitak studyoftheimmunestateindifferentvariantsofanestheticsupportfortotallaryngectomy